Video Shorts

Cutting Carbon Footprints by Two-Thirds

Closing the Quality-Supply Chain Gap

Cell & Gene Therapy Supply Chain Challenges, Explained

Are FDA Foreign Inspections Working?

Centralizing Drug Substance Data With AI-Enabled Analytics

Why Zero Complaints Is a Bad Sign

Devices Must Work for Everyone

Enthusiasm Surrounding Continuous Bioprocessing

The Future Is Here for Pharma

The Industry Inflection Point: Why the Future Is Bright

Panel on What Robotics in Aseptic Means for Operations Teams - Key Takeaway

The Biggest Takeaway on Robotics in Aseptic

Why CDMOs Must Stay Close to Industry Trends

Why Truly 'Novel' Excipients Are So Rare

Standardizing Processes for Faster Turnarounds

Why Most New Excipients Fail to Market

Automated Quality Inspections Explained

How AI Can Enhance Training

How Big Pharma Addresses Regulatory Gaps On Multiple Sites

The Essentials for AI Risk Management

Can AI Release Pharmaceutical Batches?

How AI Handles Data Integrity

Small Companies Should Stop Mimicking Big Pharma

When Do You Tweak a Method Out of Compliance?

Why Quality Systems Are Worth The Investment

Eli Lilly's $2.75B AI Move

Cutting Through the Noise in Pharma AI

How AI Can Free Pharma Teams for Higher-Value Work

Measuring AI Maturity in Pharma

Why You Can't Test 100% of Medicine